Spirea Ltd. operates as a healthcare technology company that has developed a smart polymer platform for the controlled delivery of drug combinations to maximise the clinical impact of medicines.
Stamp Free operates as a digital postage stamp company that provides postage solutions. The company provides an app that allows personal and business customers to buy stamps or digital postage directly on their mobile phones and then post their letters or parcels in the normal way.
Pommelhorse offers communication tools for work, education, health care, and personal use. Pommelhorse controls video in the real-time, frame by frame and pixel by pixel, using a combination of traditional vision algorithms and our own innovative techniques. Additionally, it develops and trains specialized models to complement or supplement our vision algorithms in order to achieve cutting-edge performance in confined spaces.
Qureight is an imaging analytics company. It also aims to develop a new improved and streamlined version of its analytical platform – harnessing the ability of AI and advanced processing tools to gain new insights into respiratory diseases such as Idiopathic Pulmonary Fibrosis (IPF) and lung cancer.
Closed Loop Medicine is the global leader in the development of single prescription drug plus digital therapy (DTx) combination products developed to optimise dosing on an individual level with linked behaviour therapy to improve patient outcomes. The company was founded by an experienced team of healthcare professionals, entrepreneurs and life scientists with experience of both drug and software development, as well as extensive health system innovation experience. The company has two products in development for hypertension and insomnia. It has further products in its pipeline for a wide portfolio of chronic diseases. The Company ensures that both patient and clinician are at the centre of its products design and development.
Forefront RF is a fabless semiconductor company.
Porotech is a spin-out from the University of Cambridge. It mainly focuses on the development of wide-bandgap compound GaN semiconductors by applying material technologies and solutions to unleash the full potential of GaN to revolutionize the electronics industry. The company was co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver.
Porotech is a spin-out from the University of Cambridge. It mainly focuses on the development of wide-bandgap compound GaN semiconductors by applying material technologies and solutions to unleash the full potential of GaN to revolutionize the electronics industry. The company was co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver.
ScaleXP is an automated analytics platform that helps small businesses consolidate their financial and sales data.
Concr is a mission-driven techbio company that uses established methods from astrophysics to accurately predict patient outcomes and treatment response to novel and existing cancer therapies. Our unique approach allows iterative learning between disparate and fragmented data across all stages of a drug’s journey into the clinic, removing the need for ‘big data’ and yielding most accurate multi-modal tumour models. Concr’s cloud native platform – FarrSight® – empowers researchers to computationally simulate clinical trials, make advanced predictions about therapeutic response and biomarkers, and perform standard bioinformatics analyses directly. Concr is headquartered in London, with a wholly-owned subsidiary in Brisbane, Australia. The company is a venture capital-backed enterprise, with investors including the University of Cambridge Enterprise, R42 Group, Oncology Ventures, Debiopharm, Cambridge Angels, Deep Science Ventures and SyndicateRoom.
Antiverse is a new type of antibody discovery company accelerating drug development. Its platform exists at the intersection of structural biology, machine learning, and medicine to enable breakthroughs to happen more quickly and cost-effectively. It is dedicated to engineering the future of drug development to change the course of people's lives.
Cambridge GaN Devices focuses on the development of gallium nitride power devices that enhance energy efficiency in electronic applications. The company offers a range of GaN-based semiconductor products designed to improve power conversion and reduce energy loss in various systems. These devices are utilized in sectors such as renewable energy, electric vehicles, and consumer electronics, contributing to the advancement of greener technologies. Cambridge GaN Devices collaborates with industry partners to drive innovation and facilitate the adoption of its technology in the power semiconductor market.
BlackCurve helps e-commerce businesses understand their competitors, and use price to improve digital marketing performance
NPT is a cleantech company that has developed a revolutionary process technology called REFNOVA. REFNOVA allows customers to converts non-food plant residues into sustainable products such as biochar, activated carbon, biofuel, biopolymers and biochemicals. Our products help customers replace fossil based products and enable decarbonisation.
Their sensors are based on film bulk acoustic resonator (FBAR) technology. The devices, fabricated on a silicon wafer, comprise a thin film of piezoelectric material that is made to resonate. Attachment of mass to the surface changes the resonant frequency and provides an extremely accurate measurement of the amount of mass on the sensing area.Their sensors are suited to applications where you need to detect small masses in a device with an extremely small form factor. Functionalising the surface of their devices means that they can selectively detect specific targets.
Spotta is the creator of an ultra-low-power insect monitoring sensor for detecting bed bug infestations. The company's sensor is battery-powered, allowing users to be notified whenever bed bugs are detected and analyzing the detection to ensure users are only notified about genuine incidents, allowing customers to prevent bed bugs from entering the room and make treatment easier and less expensive.
NPT is a cleantech company that has developed a revolutionary process technology called REFNOVA. REFNOVA allows customers to converts non-food plant residues into sustainable products such as biochar, activated carbon, biofuel, biopolymers and biochemicals. Our products help customers replace fossil based products and enable decarbonisation.
Flusso is a semiconductor company that develops and manufactures sensor solutions for various industries. It provides and offers mass flow and air velocity sensors for proprietary technology uses. Flusso was founded in 2016 and is based in Cambridge, UK.
Whether you're a patient recovering from knee surgery or a desk worker starting to feel an ache in your back, the first step to getting you back to your best is getting an accurate measurement of your issue. Vitrue's products accurately and objectively measure musculoskeletal issues from the workplace to the clinic. VIDA is a tech-driven, fully managed service to reduce musculoskeletal problems like back and neck pain in desk workers. All while making companies DSE compliant for remote, office and hybrid teams. By assessing the quality of desk workers’ workspaces through cutting-edge AI, VIDA is a modern and scalable solution with impactful benefits. 65% of employees are living with MSK issues like back or neck pain. In most cases, this is entirely preventable. With VIDA, you can empower your team to improve their workspace by giving them the knowledge they need to reduce pain and improve their quality of life. Vitrue EVVA uses depth sensors to perform clinical grade assessments of patients and is used in orthopaedics, elite sport injury prevention and preventative health screening. We provide computer vision based biomechanics measurement technology to assess your clients’ performance of gold standard functional movements pre and post treatment and throughout rehabilitation. We provide data to both clinicians and patients to ensure issues are detected early, optimal treatment can be designed and patients are informed and engaged throughout their experience. Our mission is to provide a new foundation for musculoskeletal healthcare and reduce MSK pain in millions of people.
MicrofluidX is tackling the problems of process control, scalability, and cost associated with cell bioprocessing, in particular for autologous cell and gene therapy.
Porotech is a spin-out from the University of Cambridge. It mainly focuses on the development of wide-bandgap compound GaN semiconductors by applying material technologies and solutions to unleash the full potential of GaN to revolutionize the electronics industry. The company was co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver.
Kalium Health are pioneering patient-centric approaches to help with the management of kidney disease - a growing problem costing US Medicare alone $2B every week. Value-based kidney care providers are seizing the initiative and capturing market share in the US, and now need advanced tools and data to drive cost-effective improvements in care. The first product that Kalium Health is developing is their blood potassium self-test that addresses a key risk, and huge treatment cost, in kidney disease. The team have developed proven blood sensing technology and have a clear regulatory pathway and targeted go-to-market strategy. Their ultimate vision is to transform the standard of care for millions of patients.
techspert.io uses AI for next generation primary research and business intelligence. techspert.io started life in the healthcare sector, where co-founders Graham and David personally experienced how slow, laborious and costly it was to connect to the right people. On teaming up with Hari, and developing an AI-based solution to interrogate expertise, they realised that their technology would add value across all sectors, globally, no matter how niche the expertise required. The team has now grown to include Computer Science PhDs, software developers, and experienced client relations managers, and the company is servicing large consultancies and private equity groups. They are, though, just at the start of their journey to democratise access to knowledge for a better world, and they are guided by their core values of curiosity, empathy, commitment, and ambition as they strive to revolutionise knowledge exchange.
NPT is a cleantech company that has developed a revolutionary process technology called REFNOVA. REFNOVA allows customers to converts non-food plant residues into sustainable products such as biochar, activated carbon, biofuel, biopolymers and biochemicals. Our products help customers replace fossil based products and enable decarbonisation.
Cambridge Communication Systems Ltd (CCS), a Cambridge, UK-based newly formed technology company that intends to provide a cost-effective backhaul solution for the mobile infrastructure.
PervasID is developing a high reliability, wide area passive RFID system with the potential to provide location capability based on the EPC Class1 Gen2 standard. Spun out from research activity in the Engineering Department at the University of Cambridge, the technology is now successfully deployed in several field trials.
Their sensors are based on film bulk acoustic resonator (FBAR) technology. The devices, fabricated on a silicon wafer, comprise a thin film of piezoelectric material that is made to resonate. Attachment of mass to the surface changes the resonant frequency and provides an extremely accurate measurement of the amount of mass on the sensing area.Their sensors are suited to applications where you need to detect small masses in a device with an extremely small form factor. Functionalising the surface of their devices means that they can selectively detect specific targets.
Stemnovate is a unique, innovative drug development platforms enable the right patients to be targeted with the right treatments, at the right time.
RoadMap is founded on four patents licensed from the Cambridge Centre for Advanced Photonics and Electronics (CAPE) in the area of silicon wavelength switch technology. Network operators are facing the triple challenge of increasing capacity to fulfill exploding internet data needs, managing unrelenting downward pressure on Opex and Capex costs, and supporting variable and fast evolving service features and demand patterns that put a premium on network configuration flexibility. This leads to a requirement for very flexible optical switching that can operate at the wavelength level. Conventional switch architectures no longer meet this need as they cannot accommodate next generation 400 G bps data rates.
Rovco designs an autonomous underwater vehicle or AUV and remotely operated underwater vehicle or ROV technologies and support services that optimizes how people manage and inspect subsea assets. Its technology offers the process of 3D photogrammetry that involves using high-resolution photos of a static object or site area taken from multiple angles and processed to generate a 3D vector model from point cloud data, enabling oil, gas, and renewables industry clients to evaluate their subsea assets for damage, corrosion or determining levels of marine growth and benefit from inspection related cost savings.
Closed Loop Medicine is the global leader in the development of single prescription drug plus digital therapy (DTx) combination products developed to optimise dosing on an individual level with linked behaviour therapy to improve patient outcomes. The company was founded by an experienced team of healthcare professionals, entrepreneurs and life scientists with experience of both drug and software development, as well as extensive health system innovation experience. The company has two products in development for hypertension and insomnia. It has further products in its pipeline for a wide portfolio of chronic diseases. The Company ensures that both patient and clinician are at the centre of its products design and development.
Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countries to prevent fraud and financial crime. ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.
Pathfinder Medical is developing a novel electronic guidance system that will enable clinicians to connect blood vessels in a minimally invasive way. This platform technology has a variety of clinical applications such as bypassing peripheral blockages and in vascular access creation for dialysis patients, which represents a £1.6b yearly market.
Our Vision Founded in 2016 with VR, AR and MR in mind, our vision is a world where everyone has easy access to high quality immersive content. We see VR headsets, AR and MR devices becoming readily available in public places. Imagine cardboard headsets in your local shops and communities as readily available and as easily recyclable as coffee cups. Challenges of VR, AR and MR For the masses to adopt VR, AR & MR into their daily lives there needs to be the pull of great and diverse content. Unfortunately, VR/AR/MR experiences are very hard to get right – especially for mobile. There are lots of technical challenges to achieve visually stunning and smooth performance as well as a natural interaction within a limited power budget. Our Content & Technology We are developing a strong portfolio of VR, AR & MR content covering a wide range of interactive entertainment. Entertainment such as games, interactive experiences and animated pieces. To enable the most beautiful visuals we are also working on our own technology built from scratch to meet the requirements and challenges of VR/AR/MR development. Our technology will be scalable from mobile to PC including consoles in between. This technology will enable stunning content beginning with entry level smartphones, being used with Google Cardboard. All the way up to high end PCs, powering HTC Vive and Oculus Rift platforms. Our Team Our team members are veterans from ARM and Sony Guerrilla Cambridge, responsible for leading technology advances as well as several high-profile games and experiences. This includes developing mobile tools such as the ARM DS-5 Streamline Performance Analyzer and ARM Mali Graphics Debugger, Mobile graphics demos such as Ice Cave and Timbuktu. Alongside released games such as BAFTA winning Syndey 2000, LittleBIG Planet, Killzone Shadow Fall and RIGS which was a Playstation VR launch title.
Closed Loop Medicine is the global leader in the development of single prescription drug plus digital therapy (DTx) combination products developed to optimise dosing on an individual level with linked behaviour therapy to improve patient outcomes. The company was founded by an experienced team of healthcare professionals, entrepreneurs and life scientists with experience of both drug and software development, as well as extensive health system innovation experience. The company has two products in development for hypertension and insomnia. It has further products in its pipeline for a wide portfolio of chronic diseases. The Company ensures that both patient and clinician are at the centre of its products design and development.
Libertine FPE designs and manufactures linear generator and piston power systems.
Kaptivo uses AI to make visual collaboration easier and more efficient. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. With Kaptivo, remote meetings now include live-streamed whiteboard content, with augmented capabilities including automatic note-taking. Businesses and schools use Kaptivo in conjunction with Zoom, Cisco Webex, Microsoft Teams, Slack and other collaboration tools to improve productivity while keeping content secure.
Myrtle.ai is an AI technology company. We optimize machine learning inference workloads for multiple applications in cloud or enterprise data centers and in edge applications. Our products, expertise and IP ensure all available compute resources are optimized for cost, throughput, latency and energy.
We are passionate about enabling organisations to engage and collaborate with their workforce, ecosystem, customers and the world to generate new ideas as part of a wider innovation strategy. Where innovation works! Wazoku is both a for-profit and a for-purpose business. We see innovation and sustainability as core pillar of our business. We believe every organisation can successfully innovate at scale and we're building the technology and processes to make it possible. We help global organisations to build and sustain an effective Culture of Innovation and successfully deliver innovation at scale. To help you meet your innovation challenges we created our Enterprise Innovation Platform comprising: Idea Management Software, Open Innovation Marketplace, Innovation Consulting, Portfolio Management
Focal Point consists of a team of experts with more than 30 years of combined knowledge in the world of positioning, navigation and timing. The company has revolutionised navigation and positioning software through the development of two core products: S-GNSS and D-Tail. S-GNSS drastically improves the sensitivity and accuracy of GPS receivers, making it far easier to track people indoors and in remote environments. D-Tail taps into sensors already within a smartphone or wearable device to more accurately track users in three-dimensions, producing data that can be trusted more than ever before. Founder Dr Ramsey Faragher is a world-leading expert in GNSS-denied positioning and has previously worked as a senior research associate at the University of Cambridge and a principal scientist at the BAE Systems Advanced Technology Centre, where he developed award-winning technologies. His early work included developing a range of multi-sensor positioning systems for unmanned aerial and ground vehicles and the Astute nuclear submarine. He was also part of the original design team for the ExoMars martian rover's "Seeker" visual navigation system.
At Audio Analytic, we create exceptional human experiences through a greater sense of hearing. We do this by partnering with leading consumer tech companies to bring intelligence and context to their products through an accurate, robust and compact sense of hearing. This ‘greater sense of hearing’ will help us remember the past, help, improve and extend our hearing in the present and anticipate what we need in the very near future. Our embedded software platforms (ai3™ and ai3-nano™) have been licensed to some of the world’s most prominent companies and are suitable for a wide range of products from smart speakers and video doorbells to smartphones, xR glasses and true wireless earbuds.
Heartfelt Technologies exists to help patients, their families, carers and doctors, to reduce hospital re-admission rates from congestive heart failure de-compensation.
Crayfish.io is the go-to digital platform providing quality, value-for-money online business services supporting companies engaging with cross border trade, with a focus on China. Our 24/7 online e-commerce site aims to support the businesses that are often under-served and over-charged. We offer them access to a comprehensive range of easily accessible vetted services to suit all budgets, with secure payment, online project management, fast delivery and no hidden charges. Services cover all business areas from doing B2B marketing and sourcing to setting up an office and recruiting staff - all designed to equip your business and help you overcome the challenges associated with cross-border working.
Artfinder is the art marketplace creating a world where art benefits everyone. Artfinnder connects art lovers with independent artists around the world. When you buy art from Artfinder you support independent artists in over 100 countries, helping them to make a living from art. Artfinder is the first Certified B Corporation in the art world, balancing social purpose and environmental responsibility with purpose and profit. • 600,000+ subscribers around the world • 10,000+ artists and galleries internationally • 500,000+ artworks in categories including painting, printmaking, photography, sculpture, drawing and collage
techspert.io uses AI for next generation primary research and business intelligence. techspert.io started life in the healthcare sector, where co-founders Graham and David personally experienced how slow, laborious and costly it was to connect to the right people. On teaming up with Hari, and developing an AI-based solution to interrogate expertise, they realised that their technology would add value across all sectors, globally, no matter how niche the expertise required. The team has now grown to include Computer Science PhDs, software developers, and experienced client relations managers, and the company is servicing large consultancies and private equity groups. They are, though, just at the start of their journey to democratise access to knowledge for a better world, and they are guided by their core values of curiosity, empathy, commitment, and ambition as they strive to revolutionise knowledge exchange.
Exonate is a privately held, early stage, biotech company spun out of the University of Nottingham that is focused on alternative splicing of Vascular Endothelial Growth Factor (VEGF) in ophthalmology. Exonate’s lead programme is focused on Diabetic Macular Oedema (DMO). A consequence of diabetic retinopathy, DMO, is swelling in an area of the retina called the macula and wet Age-Related Macular Degeneration (wAMD), which is the leading cause of vision loss in people aged 60 and older. The Company is founded on scientific excellence with strong links to Professor David Bates and his lab at Nottingham University specializing in the biology and biochemical pathways of VEGF splice variants. Exonate have developed small molecules that inhibit production of pro-angiogenic VEGF through selective inhibition of serine/threonine-protein kinase 1 (SRPK1)-mediated VEGF splicing. These inhibitors have already demonstrated superior efficacy as topical agents in preclinical models of wet AMD. Through a Wellcome Trust funded project, Exonate has completed an optimization programme and has nominated a pre-clinical candidate drug with optimal characteristics. During the second quarter of 2020 regulatory toxicology and safety pharmacology studies have taken place. This is to support the successful application to the regulatory authorities for clinical evaluation. Exonate is led by an experienced, international management team that has previously worked together with cross-disciplinary experience in medicine and drug development, as well as successful fundraising for early stage companies. About Diabetic Macular Oedema (DMO)*: DMO is the build-up of fluid (Oedema) in a region of the retina called the macula. The macula is important for the sharp, straight-ahead vision that is used for reading, recognizing faces, and driving. DMO is the most common cause of vision loss among people with diabetic retinopathy. About half of all people with diabetic retinopathy will develop DMO and although it is more likely to occur as diabetic retinopathy worsens, DMO can happen at any stage of the disease. About wet Age-Related Macular Degeneration (wet AMD): Today, wet AMD is a leading cause of vision loss in people aged 60 years or older and affects more than 30 million patients worldwide, over 200,000 of those in the UK alone. If untreated patients are likely to lose sight in the affected eye within 24 months of disease onset. The main currently available treatment options for DMO and wet AMD are: • anti-VEGF antibody drugs – to prevent the growth of new blood vessels in the eye. Unlike small molecule drugs or eye drops these treatments must be injected into the eye once every 1 or 2 months. Resistance can develop to these drugs causing the disease to progress anew. • Laser surgery – to destroy abnormal blood vessels in the eye. This type of surgery is only suitable if blood vessel damage is not too extensive and if the abnormal blood vessels aren't close to the fovea, as performing surgery close to this part of the eye can cause permanent vision loss. • With DMO, Corticosteroids either injected or implanted into the eye, may be used alone or in combination with other drugs or laser surgery to treat DMO. *source: https://nei.nih.gov/health/diabetic/retinopathy
Encore Musicians is a musician employment platform developer that connects individuals with musicians. The company's platform helps users find and book musicians for all types of music performances, as well as event management and other chores, allowing users to find a variety of artists for weddings, parties, charity, and business events.
Healx is a rare disease biotechnology company that uses generative AI for drug discovery. Healx utilizes advanced artificial intelligence (AI) and machine learning technologies to identify potential drug candidates and repurpose existing drugs for new therapeutic applications. By focusing on drug repurposing, Healx aims to find new uses for existing medications, leveraging their known safety profiles and reducing the risk and cost associated with developing new drugs from scratch.
Cambridge Mask Co manufactured and distributes a leading range of consumer pollution masks that use filter technology developed by the British military for chemical, nuclear and biological warfare protection. They filter nearly 100% of viruses, bacteria, gas and particulate pollution. The masks come in sizes and patterns suitable for the whole family. Cambridge Mask Co supplies clients such as the United Nations, NetJets and British Airways.
At Kheiron, we are going where only a few have gone before; seeking a new understanding of cancer and how to detect it using artificial intelligence and human insight. We’ve made significant breakthroughs with our breast cancer screening product Mia but this is just the beginning of our journey. Ultimately we want to radically improve the outcomes for cancer patients by pioneering a new era of, what we call, precision radiology. While this all sounds very serious and it is, we believe in having fun along the way. Karaoke is our favourite sport. We also have an incredible crew from more than twenty different countries and offices in London, Budapest, Amsterdam and San Francisco. Giving every woman a better fighting chance against cancer.
Arecor is a leader in developing superior biopharmaceuticals through the application of its innovative formulation technology platform. Arecor is leveraging this platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care via the innovative reformulation of approved proteins and peptides. In addition to its internal product portfolio, Arecor partners with leading pharmaceutical and biotech companies to deliver superior reformulations of their proprietary products, which would otherwise not be possible using conventional formulation science.
ThirdEye is building the world’s first real-time CCTV powered AI assistant to put in the hands of public space workers. Our context aware alert systems detect relevant events in CCTV streams and deliver notifications to staff members in real-time while our analytics tools make data-driven decision making available to brick-and-mortar retailers. We keep our clients productive and competitive in an ever evolving market.
Rabble is a privately held company that boost your fitness levels, meet people and have fun by joining a Rabble game.
Fire Sprinklers have remained fundamentally unchanged since they were invented in the 19th Century. We developed Automist Smartscan because we believed they could be better: operate faster, be more reliable and cause less water damage. Automist is trusted in both the UK and US with over 10,000 installations. It can be installed with reduced plumbing requirements, no tank or commercial water supply required, and less disruption because it uses flexible hosing and does not have to be fitted in the ceiling. Plumis recently won ‘Innovation of the Year’ at the Make UK Manufacturing Awards in January.
Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countries to prevent fraud and financial crime. ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.
DefiniGEN was founded in April 2012 to industrialize the OptiDIFF stem cell production platform developed at the University of Cambridge, UK. The company has world-leading expertise in the area of iPSC production and metabolic disease modelling. The application of these technologies in drug discovery provides pharmaceutical companies with more predictive in vitro cell products enabling the development of safer and more effective treatments. In addition the technology platform utilises fully defined and humanized conditions required for the development of regenerative medicine cellular therapies. DefiniGEN builds on intellectual property and knowledge resident at the University of Cambridge Regenerative Medicine Department at Addenbrooke’s Hospital and in addition has in-licensed the Yamanka induced pluripotent stem cell IP portfolio from iPS Academia Japan Inc.
Cambridge Nutraceuticals is based in central Cambridge. They have close ties with Cambridge University. Founded in 2012 with just one product “Ateronon”, based on their patented form of bioavailable lycopene, Cambridge Nutraceuticals has since grown significantly. In December 2015, they launched their extended range of clinically-proven supplements under their new brand FutureYou. Their aim is to develop a range of bioavailable supplements with clinically proven benefits. Cambridge Nutraceuticals product development is supported by a high profile medical board including, among others, Professor Alf Lindberg; former head of R&D at Wyeth and Aventis and former member of the Nobel Committee and Secretary of the Medical Prize, Peter Kirkpatrick BSc MBCHB MSc FRCS; a leading Cambridge University vascular neurosurgeon, and Dr Andrew Carson FRCGP; a senior NHS General Medical Practitioner.
Spectral Edge combines patented Image Fusion tech with Deep Learning to reveal more of the color, detail and clarity in any image.
At Audio Analytic, we create exceptional human experiences through a greater sense of hearing. We do this by partnering with leading consumer tech companies to bring intelligence and context to their products through an accurate, robust and compact sense of hearing. This ‘greater sense of hearing’ will help us remember the past, help, improve and extend our hearing in the present and anticipate what we need in the very near future. Our embedded software platforms (ai3™ and ai3-nano™) have been licensed to some of the world’s most prominent companies and are suitable for a wide range of products from smart speakers and video doorbells to smartphones, xR glasses and true wireless earbuds.
Repositive Ltd offers a platform that enables individuals to access and share human genomic data. The company’s platform includes features for the discovery of available data, making users’ data visible to the research community, managing users’ data sources, and initiating data collaborations. Its platform also integrates methods for secure data sharing and a mechanism for privacy-preserving data access. Repositive Ltd was incorporated in 2015 and is based in Cambridge, United Kingdom.
Axol specialize in human cell culture. Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers. These are iPSC-derived cells and the media and reagents required to successfully culture these cells. The company also do iPSC reprogramming and differentiation to various cell types as a service for customers that wish to use their own patient-derived samples. Axol is headquartered and maintains production on the Chesterford Research Park, a location renowned for inspiring innovation and success, located in Cambridge, UK.
Ieso Digital Health Ltd. specializes in providing online evidence-based cognitive behavioral therapy (CBT) to individuals facing various mental health challenges, including anxiety and depression. The company's unique online service facilitates real-time communication between accredited therapists and patients through a secure virtual environment, where sessions are conducted via text. This approach not only mirrors traditional face-to-face interactions but also offers greater convenience for users. Ieso began its operations in the UK in 2000 and has since expanded into the US market, collaborating with Medicaid and commercial health plans to enhance access to mental health services. The company’s therapy model has demonstrated effectiveness, requiring fewer sessions to achieve recovery and showing improved outcomes compared to conventional therapy methods. Ieso serves a diverse clientele, including health providers, private individuals, and businesses, and is recognized for its rapid growth in the digital health sector.
GeoSpock enables data fusion for the connected world with GeoSpock DB – the space-time analytics database. GeoSpock DB is a unique, cloud-native database optimised for querying for real-world use cases, able to fuse multiple sources of Internet of Things (IoT) data together to unlock its full value, whilst simultaneously reducing complexity and cost. GeoSpock DB enables efficient storage, data fusion, and rapid programmatic access to data, and allows you to run ANSI SQL queries and connect to standard analytics tools via flexible JDBC/ODBC connectors. Users are able to perform deep analysis and share insights using familiar toolsets, with plug and play support for common BI tools (such as Tableau™, Amazon QuickSight™, and Microsoft Power BI™), and Data Science and Machine Learning environments (including Python Notebooks and Apache Spark). The database can also be integrated with proprietary applications, web services, and internal tools – with compatibility for open-source and customisable visualisation libraries such as Kepler and Cesium.js.
Tripism is a platform for business and frequent travellers, enabling Tripism members to share business travel recommendations, tips and plans with their trusted business network.
Funderbeam is a funding and trading platform that connects companies and investors to buy and sell equity stakes. The platform allows the founders to gain exposure, legal support, a funding manager, or an investor network. It also allows the investors to take control of their investments and trade anytime they want. The company was founded in 2013 as a global data platform for startup companies.
Pekama helps companies leverage big data to manage their intellectual property. Within 30 seconds, companies can access their existing IP and build their own IP dashboard. This allows them to make data-driven, informed, decision and build a sensible strategy.
Dogtooth is a Cambridge-based technology start-up that sells state-of-the-art intelligent robots for soft fruit picking.
Cambridge Mask Co manufactured and distributes a leading range of consumer pollution masks that use filter technology developed by the British military for chemical, nuclear and biological warfare protection. They filter nearly 100% of viruses, bacteria, gas and particulate pollution. The masks come in sizes and patterns suitable for the whole family. Cambridge Mask Co supplies clients such as the United Nations, NetJets and British Airways.
Faculty is one of Europe’s leading applied artificial intelligence companies. We provide customers with decision intelligence software, Frontier, that integrates data from multiple systems to show what’s going to happen, why and what organisations should do about it. We believe that AI should be safe, ethical and beneficial across society. Those principles have shaped our work with more than 300 customers across the public and private sectors as we help them use AI to move beyond data and make better decisions.
Equity Crowdfunding in 2014
SyndicateRoom is fintech company made up of data-scientists, investment professionals, software developers and marketers with one mission: to be an early investor in every British startup success story. To do this – and make fund investors money – we don’t try to spot the next Big Thing. Instead, we apply a data-driven model to portfolio construction; a repeatable process designed to maximise returns and minimise risk for fund investors. As such, we build startup portfolios that don’t attempt to predict the future; they work to stack the odds in investors’ favour. Our fund, Access EIS, aims to build investors a diversified portfolio of 50+ companies by co‑investing exclusively with some of the UK’s best-performing angel investors.
RoadMap is founded on four patents licensed from the Cambridge Centre for Advanced Photonics and Electronics (CAPE) in the area of silicon wavelength switch technology. Network operators are facing the triple challenge of increasing capacity to fulfill exploding internet data needs, managing unrelenting downward pressure on Opex and Capex costs, and supporting variable and fast evolving service features and demand patterns that put a premium on network configuration flexibility. This leads to a requirement for very flexible optical switching that can operate at the wavelength level. Conventional switch architectures no longer meet this need as they cannot accommodate next generation 400 G bps data rates.
Sensiia is the company behind DuoFertility. It the only fertility wearable that is accompanied by a personalised service. DuoFertility is the fertility system that predicts and confirms ovulation with one-to-one support from your personal fertility expert to help you find your path to pregnancy. It identifies your most fertile window 10 days in advance, giving you the time and confidence to plan your schedule. DuoFertility has been clinically-proven and works naturally with your body. It learns your personal ovulation cycle and has been proven to be as effective as the first cycle of IVF. When tested with 99 couples who were IVF candidates, the pregnancy rate after 6 months of use was the same as for a cycle of IVF.
Undo is the time travel debugging company for Linux. We equip developers with the technology to understand complex code and fix bugs faster. Developers spend far too much time figuring out what code actually does – either to find and fix bugs or to understand other people’s code. With time travel debugging, developers can see exactly what the software did, and create better software faster. By integrating Undo’s LiveRecorder into their CI workflow, C/C++, Go, and Java software teams can easily and quickly diagnose the root causes of new regressions, legacy bugs, and flaky tests – before they hit customers. Thousands of developers across leading technology firms including SAP, Juniper Networks, and Siemens use LiveRecorder to improve developer productivity, developer velocity, and software quality.
At Audio Analytic, we create exceptional human experiences through a greater sense of hearing. We do this by partnering with leading consumer tech companies to bring intelligence and context to their products through an accurate, robust and compact sense of hearing. This ‘greater sense of hearing’ will help us remember the past, help, improve and extend our hearing in the present and anticipate what we need in the very near future. Our embedded software platforms (ai3™ and ai3-nano™) have been licensed to some of the world’s most prominent companies and are suitable for a wide range of products from smart speakers and video doorbells to smartphones, xR glasses and true wireless earbuds.
We are passionate about enabling organisations to engage and collaborate with their workforce, ecosystem, customers and the world to generate new ideas as part of a wider innovation strategy. Where innovation works! Wazoku is both a for-profit and a for-purpose business. We see innovation and sustainability as core pillar of our business. We believe every organisation can successfully innovate at scale and we're building the technology and processes to make it possible. We help global organisations to build and sustain an effective Culture of Innovation and successfully deliver innovation at scale. To help you meet your innovation challenges we created our Enterprise Innovation Platform comprising: Idea Management Software, Open Innovation Marketplace, Innovation Consulting, Portfolio Management
Grapeshot (Acquired by Oracle) empowers the world’s leading brands and advertisers to bring relevance to every customer experience. With its proprietary Contextual Intelligence platform, Grapeshot transforms information into actionable data, and identifies revenue-driving behaviors. With solutions for predictive targeting, brand safety, and audience enrichment, advertisers, media agencies, programmatic platforms and publishers use power of Grapeshot to improve media efficiency, increase customer engagement and boost brand perception with their intended audiences. It has been named “Digiday’s Best Publisher Tool” and “Best Attribution Solution for Keyword Signal,” The Drum’s “Best Attribution Solution,” and the British Media Awards’ “Ad Provider of the Year,” among other honors. Grapeshot entered the market in 2006, and has offices in San Francisco, Los Angeles, Chicago, Toronto, New York, London, Cambridge, Singapore, Hong Kong, Shanghai and Sydney.
Fleep is a web, Android, iOS, Mac and Windows app that wants to bridge the gap between ‘reply all’-style group email and enterprise messaging/IM services. Founded by ex-Skypers, Fleep is a messaging service that fills the gap between email and various IM/texting services. They take email’s ability to contact anyone and marry it with real-time messaging. They are based in Estonia, with offices in Tallinn and Tartu. Their services are hosted on Amazon EC2 in Dublin, Ireland.
Mawsonia is a global multimedia publishing group dedicated to serving the intermediaries, such as corporations, universities and government, direct funding to entrepreneurs in the innovation economy
Oxford Space Systems is a multi-award-winning, record-breaking venture capital backed, space tech business that's developing a new generation of deployable antennas and space structures for the global satellite industry. Using both innovative design techniques such as origami and novel proprietary materials developed by the company, OSS' structures are lighter, less complex and lower cost than alternatives in commercial demand. Founded in late 2013, OSS set a record for the space sector with it's AstroTube Boom: the fastest development of a new product from concept to successful deployment on orbit in under 30 months. Today, the 18 strong and growing OSS team is a diverse mix of international graduates and experienced space industry professionals, with over 100 years of combined space sector experience. OSS investors include a small syndicate of UK venture capital funds together US based investors, Space Angels. Oxford Space Systems has successfully completed a number of UK government supported co-developments with leading European satellite builders as well straight commercial contracts in both Asia and the US. As part of its planned expansion, OSS move into its own custom facility at the Harwell Space Cluster in August 2018, giving it the largest clean room at the cluster. The facility will meet required security standards to undertake UK government defense & security contracts. .
TransparentChoice helps organizations measure and understand how their projects (live and potential) support their strategic goals. This leads to better decisions about projects and resources, decisions with stronger buy-in, helping them deliver more value from their portfolio.
PatientSource is an integrated clinical user interface that improves patient safety and quality of care.
Xsilon provides a range of machine-to-machine home automation solutions and networking technologies for energy measurement and control. The company’s single-chip silicon solution combines an energy usage sensor, application processor, and powerline comms modem, which communicates via the main wiring, can retrofit to any existing appliance, and facilities the remote control of appliances. Xsilon was founded by Russell Haggar and Mike Baker in 2008 and is based in England.
PneumaCare is focused on development of products for diagnosis and monitoring of respiratory disease using novel 3D imaging technology, developed by the University of Cambridge. The Company’s first product is a non–contact respiratory monitoring system for physician assessment, called PneumaScan™, which has clinical applications in a number of medical environments. Using PneumaScan™, patients can be assessed while breathing naturally or performing spirometric manoeuvres without the need to breathe into, interact with or contact the measuring device. PneumaCare's products, the PneumaScan™ family, enables clinicians to access many different patient-types, many of which are not within the capabilities of current clinical devices. The system is being constantly evaluated in clinical practice, currently at Addenbrooke’s Hospital in Cambridge, Great Ormond Street Children’s Hospital in London and in development laboratories at its design and manufacturing partner, Plextek. PneumaScan™ produces standard medical outputs for a broader portion of the population because it observes patients from a distance and does not impede the respiratory system as with current spirometer technology. Measuring from a distance means lower infection risk, less harm, reduced patient discomfort and minimal instrument running costs from having to replace or sterilise parts which have contacted the patient.
Unbound is an innovative online crowd-funded publisher that enables authors to present their book ideas directly to readers. Through this platform, readers can pledge their support for projects they find appealing. Once a book garners sufficient backing to ensure financial viability, the author proceeds with writing, while Unbound manages the subsequent processes of editing, typesetting, printing, and distribution. Notably, the names of all the supporters who contributed to the project are included in the published work. This model not only fosters a collaborative relationship between authors and readers but also enhances the publishing landscape by allowing for diverse voices and ideas to emerge.
Blu Wireless Technology is a Silicon IP company already demonstrating its 60GHz technology to meet this emerging WiGig standard. Targeting power sensitive mobile applications as well as long range access points, licensing their technology as a complete System IP solution. Their technology delivers data rates of multiple Gbps and ranges over 300m, but there’s a lot more to be gained by choosing to work with us. Their sophisticated system expertise, from mmWave silicon IP to intelligent, deep domain technology and market understanding, means that their partners and customers can have confidence in their promise to deliver a unique product that sets them apart from the competition, in a cost-effective and timely manner.
Eagle Genomics is a enterprise software solutions company whose products enable the management, orchestration and exploitation of genomics and other life sciences data. They help Life Science companies get the maximum value from their R&D data and they are delivering the information architecture for the genomics era. Their suite of software products radically reduces cost and time to complete research, enabling drastic productivity improvements. Their architecture translates data sets into data assets, redefining the current paradigm in the industry, enabling the objective measurement of the value of digital assets and providing clarity on “return on information”. Their mix of expertise in biology, bioinformatics, data science and enterprise-class software engineering is unique in the field and has been applied over the last decade to solve their customers’ challenges in areas as diverse as drug development, personal hygiene and plant breeding. With global customers in the pharmaceuticals, fast moving consumer goods and agri-tech industries they understand the common challenges facing these industries in the handling of ever growing of data and information resources. Eagle Genomics is at the forefront in addressing the challenges, risks, and opportunities in delivering the enterprise information architecture for the genomics era.
Apperio’s legal spend management software provides real-time visibility to help control and optimize external spending with law firms. Data is gathered automatically, structured consistently, and presented simply for analysis to help clients make informed business decisions. Their unique approach of connecting directly with law firms’ practice management systems provides ongoing and historical data at the touch of a button. This gives you complete cost certainty on both billed matters and work-in-progress legal fees. Apperio helps in-house teams to stay in control of their legal spending and build trust with external counsel by offering a collaborative, rather than an adversarial approach to legal spend management.
Lungfish provides sleek, light-weight rebreathers with the most advanced safety-features.
Cambridge Communication Systems Ltd (CCS), a Cambridge, UK-based newly formed technology company that intends to provide a cost-effective backhaul solution for the mobile infrastructure.
Sphere Fluidics Limited is a new Life Sciences company which has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D services in this area.
Vantage Power design and manufacture retrofit hybrid powertrains for buses, enabling operators to reduce their fuel consumption and emissions at a fraction of the cost of purchasing new hybrid buses. By designing the whole hybrid system - everything between the fuel tank and the wheels - we ensure optimal performance of every component, resulting in higher fuel economy, lower emissions, and greater reliability than other systems. The company's engineering team - drawn from the heavy-duty vehicle, Formula 1 and aerospace industries - is continuously challenged to develop innovative solutions, and this has culminated in a truly unique product offering.
Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countries to prevent fraud and financial crime. ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.
Undo is the time travel debugging company for Linux. We equip developers with the technology to understand complex code and fix bugs faster. Developers spend far too much time figuring out what code actually does – either to find and fix bugs or to understand other people’s code. With time travel debugging, developers can see exactly what the software did, and create better software faster. By integrating Undo’s LiveRecorder into their CI workflow, C/C++, Go, and Java software teams can easily and quickly diagnose the root causes of new regressions, legacy bugs, and flaky tests – before they hit customers. Thousands of developers across leading technology firms including SAP, Juniper Networks, and Siemens use LiveRecorder to improve developer productivity, developer velocity, and software quality.
Cambridge Communication Systems Ltd (CCS), a Cambridge, UK-based newly formed technology company that intends to provide a cost-effective backhaul solution for the mobile infrastructure.
Arachnys provides cloud-based solutions for assessing financial crime customer risk and CDD, KYC, and EDD compliance. It consolidates valuable business information from emerging markets to help companies increase opportunities and reduce risk in complex but attractive markets like India, China, Russia, and the Middle East. Emerging markets are seeing an explosion of business information coming online, but information is fragmented, badly organized, and often unsearchable. Current business information providers' models focus on easy-to-obtain data but do not allow for the extraction of important data locked into siloed corporate and governmental datasets. Arachnys uses domain expertise from the security and investigative industry alongside innovative spidering and scraping technology to identify high-value information buried in the deep web and make it searchable and accessible to businesses - investment banks, hedge funds, law firms, accountants, and risk consultancies - who are increasingly looking to emerging markets for growth.
CamStent Ltd is an emerging medical materials company based in Cambridge, UK. They are focused on building revenues through the development and licensing of proprietary polymer coatings that resist attachment of biofilms.
PneumaCare is focused on development of products for diagnosis and monitoring of respiratory disease using novel 3D imaging technology, developed by the University of Cambridge. The Company’s first product is a non–contact respiratory monitoring system for physician assessment, called PneumaScan™, which has clinical applications in a number of medical environments. Using PneumaScan™, patients can be assessed while breathing naturally or performing spirometric manoeuvres without the need to breathe into, interact with or contact the measuring device. PneumaCare's products, the PneumaScan™ family, enables clinicians to access many different patient-types, many of which are not within the capabilities of current clinical devices. The system is being constantly evaluated in clinical practice, currently at Addenbrooke’s Hospital in Cambridge, Great Ormond Street Children’s Hospital in London and in development laboratories at its design and manufacturing partner, Plextek. PneumaScan™ produces standard medical outputs for a broader portion of the population because it observes patients from a distance and does not impede the respiratory system as with current spirometer technology. Measuring from a distance means lower infection risk, less harm, reduced patient discomfort and minimal instrument running costs from having to replace or sterilise parts which have contacted the patient.
Neul, a Cambridge, UK-based company that develops wireless network technology to enable the use of TV “white space†spectrum.
Altacor develops and brings to market specialist ophthalmic products designed for the needs of both ophthalmologists and patients. Altacor brings together skills in drug development with in-depth market knowledge and an understanding of the European regulatory environment, to create a portfolio of high quality, differentiated prescription medicines that set new standards in the sector. Altacor's pipeline includes products for dry-eye, glaucoma, glaucoma surgery and ocular surgery.
At Audio Analytic, we create exceptional human experiences through a greater sense of hearing. We do this by partnering with leading consumer tech companies to bring intelligence and context to their products through an accurate, robust and compact sense of hearing. This ‘greater sense of hearing’ will help us remember the past, help, improve and extend our hearing in the present and anticipate what we need in the very near future. Our embedded software platforms (ai3™ and ai3-nano™) have been licensed to some of the world’s most prominent companies and are suitable for a wide range of products from smart speakers and video doorbells to smartphones, xR glasses and true wireless earbuds.